BAUSCH + LOMB CORP (BLCO) Fundamental Analysis & Valuation

NYSE:BLCO • CA0717051076

Current stock price

16.35 USD
-0.14 (-0.85%)
Last:

This BLCO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BLCO Profitability Analysis

1.1 Basic Checks

  • BLCO had positive earnings in the past year.
  • In the past year BLCO had a positive cash flow from operations.
  • In multiple years BLCO reported negative net income over the last 5 years.
  • Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • With a decent Return On Assets value of -2.57%, BLCO is doing good in the industry, outperforming 69.68% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -5.58%, BLCO is in the better half of the industry, outperforming 70.21% of the companies in the same industry.
  • BLCO has a better Return On Invested Capital (1.23%) than 67.55% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is significantly below the industry average of 9.39%.
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROIC 1.23%
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • BLCO has a better Operating Margin (3.69%) than 68.62% of its industry peers.
  • BLCO's Operating Margin has declined in the last couple of years.
  • BLCO has a better Gross Margin (59.81%) than 61.17% of its industry peers.
  • In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 59.81%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1

2. BLCO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
  • The number of shares outstanding for BLCO has been increased compared to 1 year ago.
  • BLCO has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BLCO is higher compared to a year ago.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.87, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BLCO (0.87) is comparable to the rest of the industry.
  • BLCO has a Debt/Equity ratio of 0.78. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
  • BLCO's Debt to Equity ratio of 0.78 is on the low side compared to the rest of the industry. BLCO is outperformed by 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACC0.17
WACC7.08%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that BLCO should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.55, BLCO is doing worse than 75.00% of the companies in the same industry.
  • A Quick Ratio of 1.04 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO's Quick ratio of 1.04 is on the low side compared to the rest of the industry. BLCO is outperformed by 78.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.04
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. BLCO Growth Analysis

3.1 Past

  • BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.35%.
  • Looking at the last year, BLCO shows a small growth in Revenue. The Revenue has grown by 6.47% in the last year.
  • Measured over the past years, BLCO shows a quite strong growth in Revenue. The Revenue has been growing by 8.38% on average per year.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%

3.2 Future

  • BLCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.28% yearly.
  • The Revenue is expected to grow by 5.41% on average over the next years.
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue Next Year7.01%
Revenue Next 2Y6.29%
Revenue Next 3Y5.98%
Revenue Next 5Y5.41%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0.5 1 1.5 2

4

4. BLCO Valuation Analysis

4.1 Price/Earnings Ratio

  • BLCO is valuated quite expensively with a Price/Earnings ratio of 32.70.
  • Compared to the rest of the industry, the Price/Earnings ratio of BLCO indicates a somewhat cheap valuation: BLCO is cheaper than 71.28% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of BLCO to the average of the S&P500 Index (26.17), we can say BLCO is valued slightly more expensively.
  • Based on the Price/Forward Earnings ratio of 20.24, the valuation of BLCO can be described as rather expensive.
  • BLCO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 77.66% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BLCO to the average of the S&P500 Index (23.05), we can say BLCO is valued inline with the index average.
Industry RankSector Rank
PE 32.7
Fwd PE 20.24
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BLCO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 76.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.33
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BLCO's earnings are expected to grow with 40.86% in the coming years.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y47.88%
EPS Next 3Y40.86%

0

5. BLCO Dividend Analysis

5.1 Amount

  • BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BLCO Fundamentals: All Metrics, Ratios and Statistics

BAUSCH + LOMB CORP

NYSE:BLCO (4/6/2026, 11:06:45 AM)

16.35

-0.14 (-0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)04-29
Inst Owners10.27%
Inst Owner Change0%
Ins Owners0.48%
Ins Owner Change17.19%
Market Cap5.81B
Revenue(TTM)5.10B
Net Income(TTM)-360.00M
Analysts71.58
Price Target18.83 (15.17%)
Short Float %10.34%
Short Ratio9.67
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-10.76%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-90.21%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)-43.92%
EPS beat(12)8
Avg EPS beat(12)-25.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.58%
EPS NQ rev (1m)2.78%
EPS NQ rev (3m)-32.73%
EPS NY rev (1m)0%
EPS NY rev (3m)1.37%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.81%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 32.7
Fwd PE 20.24
P/S 1.14
P/FCF N/A
P/OCF 20.51
P/B 0.9
P/tB N/A
EV/EBITDA 17.33
EPS(TTM)0.5
EY3.06%
EPS(NY)0.81
Fwd EY4.94%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)0.8
OCFY4.87%
SpS14.37
BVpS18.16
TBVpS-4.48
PEG (NY)0.53
PEG (5Y)N/A
Graham Number14.29
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROCE 1.55%
ROIC 1.23%
ROICexc 1.27%
ROICexgc 4.04%
OM 3.69%
PM (TTM) N/A
GM 59.81%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
ROICexc(3y)1.38%
ROICexc(5y)1.81%
ROICexgc(3y)4.6%
ROICexgc(5y)6.09%
ROCE(3y)1.7%
ROCE(5y)2.22%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y-11.42%
ROICexc growth 3Y-14.77%
ROICexc growth 5Y-9.61%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 8.28
Cap/Depr 82.9%
Cap/Sales 6.84%
Interest Coverage 0.49
Cash Conversion 46.47%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.04
Altman-Z 0.87
F-Score3
WACC7.08%
ROIC/WACC0.17
Cap/Depr(3y)65.67%
Cap/Depr(5y)57.94%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%
Revenue Next Year7.01%
Revenue Next 2Y6.29%
Revenue Next 3Y5.98%
Revenue Next 5Y5.41%
EBIT growth 1Y-7.39%
EBIT growth 3Y-8.57%
EBIT growth 5Y-6.91%
EBIT Next Year65.28%
EBIT Next 3Y27.94%
EBIT Next 5Y20.35%
FCF growth 1Y-11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3Y-6.39%
OCF growth 5Y-11.52%

BAUSCH + LOMB CORP / BLCO Fundamental Analysis FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Fairly Valued.


What is the profitability of BLCO stock?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BLCO stock?

The Price/Earnings (PE) ratio for BAUSCH + LOMB CORP (BLCO) is 32.7 and the Price/Book (PB) ratio is 0.9.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.